Ozempic-like weight loss drugs may help the heart recover after a heart attack
A University of Bristol study published in Nature Communications reports that GLP-1 weight-loss drugs (e.g., Ozempic, Wegovy, Mounjaro) activate KATP channels in coronary pericytes, restoring microvascular blood flow after myocardial infarction. The paper links brain–gut–heart signalling to cardioprotection and suggests GLP-1 agents could reduce persistent capillary no-reflow despite epicardial artery reopening.
Why it mattersUniversity of Bristol shows GLP-1 drugs activate coronary pericyte KATP channels post‑heart attack; prioritize cardiovascular outcome trials.
Entities Mentioned
University of BristolNature Communications